CRP and metabolic syndrome: Preliminary clinical evidence has linked these adipose tissue-derived hormones to measures of atherosclerosis and to development of future cardiovascular events [35], suggesting that adiponectin, leptin and C-reactive protein (CRP) may play an important role for increased risk of cardiovascular mortality in individuals with the metabolic syndrome.